A
Alain Cohen-Solal
Researcher at University of Paris
Publications - 109
Citations - 10766
Alain Cohen-Solal is an academic researcher from University of Paris. The author has contributed to research in topics: Heart failure & Ejection fraction. The author has an hindex of 37, co-authored 109 publications receiving 8770 citations. Previous affiliations of Alain Cohen-Solal include University Health Network & Paris Diderot University.
Papers
More filters
Journal ArticleDOI
The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis.
John G.F. Cleland,Karl Swedberg,Ferenc Follath,Michel Komajda,Alain Cohen-Solal,J.C. Aguilar,Rainer Dietz,Antonello Gavazzi,R. Hobbs,Jerzy Korewicki,Hugo Madeira,V. S. Moiseyev,István Préda,W. H. Van Gilst,J Widimsky,Nick Freemantle,Joanne Eastaugh,James Mason +17 more
TL;DR: Most men but a minority of women who underwent investigation of cardiac function had evidence of moderate or severe left ventricular dysfunction, the main target of current advances in the treatment of heart failure.
Journal ArticleDOI
The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment.
Michel Komajda,Ferenc Follath,Karl Swedberg,John G.F. Cleland,J.C. Aguilar,Alain Cohen-Solal,Rainer Dietz,Antonello Gavazzi,W. H. Van Gilst,R. Hobbs,Jerzy Korewicki,Hugo Madeira,V. S. Moiseyev,István Préda,J Widimsky,Nick Freemantle,Joanne Eastaugh,James Mason +17 more
TL;DR: The results suggest that the prescription of recommended medications including ACE inhibitors and beta-blockers remains limited and that the daily dosage remains low, particularly for beta- blockers.
Journal ArticleDOI
Levosimendan vs Dobutamine for Patients With Acute Decompensated Heart Failure: The SURVIVE Randomized Trial
Alexandre Mebazaa,Markku S. Nieminen,Milton Packer,Alain Cohen-Solal,Franz X. Kleber,Stuart J. Pocock,Roopal Thakkar,Robert J. Padley,Pentti Põder,Matti Kivikko,Survive Investigators +10 more
TL;DR: The SURVIVE trial as mentioned in this paper was a randomized, double-blind trial comparing the efficacy and safety of intravenous levosimendan or dobutamine in 1327 patients with acute decompensated heart failure who required inotropic support.
Journal ArticleDOI
State of the art: using natriuretic peptide levels in clinical practice.
Alan S. Maisel,Alan S. Maisel,Christian Mueller,Kirkwood F. Adams,Stefan D. Anker,Nadia Aspromonte,John G.F. Cleland,Alain Cohen-Solal,Ulf Dahlström,Anthony N. DeMaria,Salvatore Di Somma,Gerasimos Filippatos,Gregg C. Fonarow,P. Jourdain,Michel Komajda,Peter P. Liu,Theresa McDonagh,Kenneth McDonald,Alexandre Mebazaa,Markku S. Nieminen,W. Frank Peacock,Marco Tubaro,Roberto Valle,Marc Vanderhyden,Clyde W. Yancy,Faiez Zannad,Eugene Braunwald +26 more
TL;DR: Ten key messages to clinicians are highlighted about the role of NP levels in state‐of‐the‐art clinical practice is evolving rapidly.
Journal ArticleDOI
Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey.
John G.F. Cleland,Alain Cohen-Solal,J. Cosin Aguilar,Rainer Dietz,Joanne Eastaugh,Ferenc Follath,Nick Freemantle,Antonello Gavazzi,W. H. Van Gilst,F. D. R. Hobbs,Jerzy Korewicki,Hugo Madeira,István Préda,Karl Swedberg,J Widimsky +14 more
TL;DR: The inconsistencies between physicians' knowledge and the treatment that they deliver suggests that improved organisation of care for heart failure is required, and there are substantial variations in practice between countries.